Communications publiées lors de congrès ou colloques nationaux et internationaux (118)
57.
Demonte, D., Goffin, V., Vanhulle, C., Collette, Y., Veithen-Fort, E., Burny, A., & Van Lint, C. (2003). The HIV-1 intragenic enhancer is important for viral replication. Abstract of the 2003 International Meeting of the Institute of Human Virology (29 Sept-3 Oct, 2003: Baltimore, USA)58.
Demonte, D., Quivy, V., Adam, E., Moutschen, M., Hermans, P., Burny, A., Piette, J., & Van Lint, C. (2003). Deacetylase inhibitors: a new hope in eradication of HIV-1 latent reservoirs? Abstract of the 1st International Workshop on HIV Persistence during Therapy (10-12 Dec, 2003: Saint Martin, French West Indies)59.
Adam, E., Quivy, V., Bex, F., Schoonbroodt, S., Burny, A., Bours, V., Piette, J., & Van Lint, C. (2002). Potentiation of TNF-induced NF-kB activation by deacetylase inhibitors is associated with a delay in the recovery of IkBalpha. Abstract of the Meeting « Cell signaling, transcription and translation as therapeutic targets » (30 Jan-2 Feb, 2002: European Conference Center Kirchberg-Luxembourg)60.
Quivy, V., Adam, E., Collette, Y., Burny, A., Piette, J., & Van Lint, C. (2002). Synergistic activation of HIV-1 promoter activity by NF-kappaB and inhibitors of deacetylases: implications for the development of therapeutic strategies. Abstract of the Meeting « Cell signaling, transcription and translation as therapeutic targets " (30 Jan-2 Feb, 2002: Luxembourg, European Conference Center Kirchberg-Luxembourg)61.
Goffin, V., Demonte, D., Vanhulle, C., Collette, Y., Veithen-Fort, E., Burny, A., & Van Lint, C. (2002). Functional analysis of the transcriptional enhancer located in the pol gene of HIV-1. Abstract of the Meeting « Cell signaling, transcription and translation as therapeutic targets » (30 Jan- 2 Feb, 2002: Luxembourg, European Conference Center Kirchberg-Luxembourg)62.
Nguyen, T. L.-A., Adam, E., Calomme, C., Nizet, S., Brenner, C., Burny, A., De Launoit, Y., & Van Lint, C. (2002). Synergistic activation of the BLV promoter transcriptional activity by TaxBLV and inhibitors of deacetylases. Abstract of the Meeting « Controls of Gene Expression » of the Belgian Society of Biochemistry and Molecular Biology (BSBMB) (22 Feb, 2002: Gosselies, Belgium)63.
Calomme, C., Adam, E., Nguyen, T. L.-A., Dekoninck, A., Nizet, S., Burny, A., & Van Lint, C. (2002). Positive and negative regulation of Bovine Leukemia Virus gene expression by four E-box motifs. Abstract of the Meeting « Controls of Gene Expression » of the Belgian Society of Biochemistry and Molecular Biology (BSBMB) (22 Feb, 2002: Gosselies, Belgium)64.
Goffin, V., Demonte, D., Vanhulle, C., Collette, Y., Veithen-Fort, E., Burny, A., & Van Lint, C. (2002). Characterization of the transcriptional enhancer located in the pol gene of HIV-1. Abstract of the Meeting « Controls of Gene Expression » of the Belgian Society of Biochemistry and Molecular Biology (BSBMB) (22 Feb, 2002: Gosselies, Belgium)65.
Quivy, V., Adam, E., Collette, Y., Demonte, D., Chariot, A., Vanhulle, C., Berkhout, B., Castellano, R., De Launoit, Y., Burny, A., Piette, J., Bours, V., & Van Lint, C. (2002). Synergistic activation of HIV-1 promoter activity by NF-kappaB and inhibitors of deacetylases: implications for the development of therapeutic strategies. Abstract of the Meeting « Controls of Gene Expression » of the Belgian Society of Biochemistry and Molecular Biology (BSBMB) (22 Feb, 2002: Gosselies, Belgium)66.
Cauvin, C., Boland, S., Demonte, D., Van Lint, C., & Durant, F. (2002). Quinoline-2,4(1H,3H)-diones as potential non nucleoside reverse transcriptase inhibitors. Abstract of the meeting “Drug Hunting: new targets, new tools, new drugs” (one day symposium organised by the Medicinal Chemistry Division of the Société Royale de Chimie) (15 Nov, 2002: Brussels, Belgium)67.
Quivy, V., Adam, E., Colette, Y., Burny, A., Piette, J., Bours, V., & Van Lint, C. (2001). Synergistic activation of HIV-1 promoter transcriptional activity by NF-kB and deacetylase inhibitor, Trichostatin A (TSA). Abstract of the 2001 International Meeting of the Institute of Human Virology, A Symposium on HIV-AIDS and Related Viral Carcinogenesis (September 9-13, 2001: Baltimore, Maryland, USA)68.
Quivy, V., Adam, E., Colette, Y., Burny, A., Piette, J., Bours, V., & Van Lint, C. (2001). Synergistic activation of HIV-1 promoter transcriptional activity by NF-kB and deacetylase inhibitor, Trichostatin A (TSA). Abstract of the Cold Spring Harbor Laboratory: Mechanisms of Eukaryotic transcription (August 29-September 2, 2001: Cold Spring Harbor, New York, USA)